• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斑秃的诊断与管理:沙特专家共识声明(2023年)

Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023).

作者信息

Fatani Mohammad Ibrahim Ahmad, Alkhalifah Abdullah, Alruwaili Amaal Farhan Salman, Alharbi Aymen Hamed Salem, Alharithy Ru'aa, Khardaly Amr Mohammad, Almudaiheem Hajer Yousef, Al-Jedai Ahmed, Eshmawi Maysa Tariq Yousef

机构信息

Department of Dermatology, Hera General Hospital, Ministry of Health, Makkah, Saudi Arabia.

Department of Dermatology and Dermatologic Surgery, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

出版信息

Dermatol Ther (Heidelb). 2023 Oct;13(10):2129-2151. doi: 10.1007/s13555-023-00991-3. Epub 2023 Aug 9.

DOI:10.1007/s13555-023-00991-3
PMID:37558830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10539276/
Abstract

Alopecia areata (AA) is a complex autoimmune disease manifesting as a chronic inflammatory disease characterized by non-scarring patches of hair loss over the face, scalp, and body. Several treatments have been proposed for AA, but none are curative nor achieve a state of remission. The present consensus statement aims to present the evidence- and experience-based recommendations on the diagnosis and management of AA in Saudi Arabia. The Ministry of Health in Saudi Arabia has opted to initiate a meeting of a multidisciplinary group to discuss and concede on this topic. Eight dermatology experts and clinical pharmacists convened in eight consensus meetings. All content presented in this document was agreed upon by this working group, including diagnosis and severity assessment, prognostic indicators, and therapeutic options for AA. Special consideration was given to special patient populations including pediatric patients and patients with less frequent presentations of AA. Updates of the current recommendations will take place as new evidence evolves in the treatment of AA.

摘要

斑秃(AA)是一种复杂的自身免疫性疾病,表现为一种慢性炎症性疾病,其特征是面部、头皮和身体出现非瘢痕性脱发斑。针对斑秃已提出了几种治疗方法,但均无法治愈,也无法实现缓解状态。本共识声明旨在提出基于证据和经验的关于沙特阿拉伯斑秃诊断和管理的建议。沙特阿拉伯卫生部已决定召开一次多学科小组会议,以讨论并就该主题达成一致意见。八位皮肤科专家和临床药剂师参加了八次共识会议。本文件中提出的所有内容均得到该工作组的认可,包括斑秃的诊断和严重程度评估、预后指标以及治疗选择。特别考虑了特殊患者群体,包括儿科患者和斑秃发病率较低的患者。随着斑秃治疗方面新证据的出现,将对当前建议进行更新。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac65/10539276/485eb9521243/13555_2023_991_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac65/10539276/6c7d6ec48ee5/13555_2023_991_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac65/10539276/929e94c4f191/13555_2023_991_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac65/10539276/485eb9521243/13555_2023_991_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac65/10539276/6c7d6ec48ee5/13555_2023_991_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac65/10539276/929e94c4f191/13555_2023_991_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac65/10539276/485eb9521243/13555_2023_991_Fig3_HTML.jpg

相似文献

1
Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023).斑秃的诊断与管理:沙特专家共识声明(2023年)
Dermatol Ther (Heidelb). 2023 Oct;13(10):2129-2151. doi: 10.1007/s13555-023-00991-3. Epub 2023 Aug 9.
2
The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.斑秃严重度和发病率指数(ASAMI)研究:全球专家共识关于斑秃严重度决定因素的结果。
JAMA Dermatol. 2024 Mar 1;160(3):341-350. doi: 10.1001/jamadermatol.2023.5869.
3
The Saudi consensus recommendations for the management of psoriatic arthritis (2023).沙特阿拉伯银屑病关节炎管理共识建议(2023 年)。
Clin Rheumatol. 2024 Mar;43(3):879-894. doi: 10.1007/s10067-024-06867-x. Epub 2024 Jan 13.
4
Treatment of alopecia areata: An Australian expert consensus statement.斑秃治疗:澳大利亚专家共识声明。
Australas J Dermatol. 2019 May;60(2):163-170. doi: 10.1111/ajd.12941. Epub 2018 Nov 8.
5
National Saudi Consensus Statement on the Management of Atopic Dermatitis (2021).沙特阿拉伯特应性皮炎管理国家共识声明(2021年)
Dermatol Ther (Heidelb). 2022 Jul;12(7):1551-1575. doi: 10.1007/s13555-022-00762-6. Epub 2022 Jul 4.
6
Quality of life measurement in alopecia areata. Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes.斑秃患者生活质量的评估。欧洲皮肤病学会和性病学会生活质量和以患者为中心结局工作组的立场声明。
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):1614-1621. doi: 10.1111/jdv.17370. Epub 2021 Jun 9.
7
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.用于临床的斑秃量表的开发:一项学术-产业合作成果
J Am Acad Dermatol. 2022 Feb;86(2):359-364. doi: 10.1016/j.jaad.2021.08.043. Epub 2021 Aug 30.
8
Dermatologist and Patient Perceptions of Treatment Success in Alopecia Areata and Evaluation of Clinical Outcome Assessments in Japan.日本皮肤科医生和患者对斑秃治疗成功率的看法及临床疗效评估
Dermatol Ther (Heidelb). 2021 Apr;11(2):433-447. doi: 10.1007/s13555-020-00477-6. Epub 2021 Jan 10.
9
IADVL SIG Pediatric Dermatology (Academy) Recommendations on Childhood Alopecia Areata.国际皮肤性病学会儿童皮肤病学(学会)关于儿童斑秃的建议。
Indian Dermatol Online J. 2022 Oct 31;13(6):710-720. doi: 10.4103/idoj.idoj_54_22. eCollection 2022 Nov-Dec.
10
Prescription Pattern of Tofacitinib for Alopecia Areata Among the Dermatologists in Saudi Arabia: A Cross-Sectional Study.沙特阿拉伯皮肤科医生治疗斑秃的托法替布处方模式:一项横断面研究
Cureus. 2023 Jun 15;15(6):e40445. doi: 10.7759/cureus.40445. eCollection 2023 Jun.

引用本文的文献

1
Evaluation of the efficacy of excimer light versus topical trichloroacetic acid (TCA) 35% in the treatment of patchy alopecia areata of the scalp.准分子光与35%外用三氯乙酸(TCA)治疗头皮斑秃疗效的评估。
Arch Dermatol Res. 2025 Feb 22;317(1):453. doi: 10.1007/s00403-025-03922-8.
2
Awareness, Beliefs, and Psychological Impact of Patients with Alopecia Areata in Saudi Arabia: A Multi-Center Study.沙特阿拉伯斑秃患者的认知、信念及心理影响:一项多中心研究
Patient Prefer Adherence. 2024 Dec 20;18:2597-2607. doi: 10.2147/PPA.S486039. eCollection 2024.
3
Budget impact analysis of baricitinib for treatment of alopecia areata: A Saudi hospital perspective.

本文引用的文献

1
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.利特昔替尼治疗成人和青少年斑秃的疗效和安全性:一项随机、双盲、多中心、2b-3 期临床试验。
Lancet. 2023 May 6;401(10387):1518-1529. doi: 10.1016/S0140-6736(23)00222-2. Epub 2023 Apr 14.
2
Two Phase 3 Trials of Baricitinib for Alopecia Areata.两项关于巴瑞替尼治疗斑秃的3期试验。
N Engl J Med. 2022 May 5;386(18):1687-1699. doi: 10.1056/NEJMoa2110343. Epub 2022 Mar 26.
3
Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata.
巴瑞替尼治疗斑秃的预算影响分析:沙特一家医院的视角
Saudi Pharm J. 2024 Dec;32(12):102204. doi: 10.1016/j.jsps.2024.102204. Epub 2024 Nov 8.
评估利特昔替尼治疗斑秃的治疗潜力。
Drug Des Devel Ther. 2022 Feb 17;16:363-374. doi: 10.2147/DDDT.S334727. eCollection 2022.
4
Alopecia areata: Current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines.斑秃:对病理生理学的当前认识及治疗方法的更新,以日本皮肤病协会指南为特色
J Dermatol. 2022 Jan;49(1):19-36. doi: 10.1111/1346-8138.16207. Epub 2021 Oct 28.
5
Development of the alopecia areata scale for clinical use: Results of an academic-industry collaborative effort.用于临床的斑秃量表的开发:一项学术-产业合作成果
J Am Acad Dermatol. 2022 Feb;86(2):359-364. doi: 10.1016/j.jaad.2021.08.043. Epub 2021 Aug 30.
6
Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study.口服Janus激酶抑制剂巴瑞替尼治疗成人生斑秃的疗效和安全性:一项随机对照研究的2期结果
J Am Acad Dermatol. 2021 Oct;85(4):847-853. doi: 10.1016/j.jaad.2021.05.050. Epub 2021 Jun 16.
7
Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology.斑秃治疗共识 - 巴西皮肤病学会
An Bras Dermatol. 2020 Nov-Dec;95 Suppl 1(Suppl 1):39-52. doi: 10.1016/j.abd.2020.05.006. Epub 2020 Oct 8.
8
The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata.斑秃专家共识(ACE)研究第二部分:关于斑秃诊断和实验室评估的国际专家意见结果
J Am Acad Dermatol. 2021 Jun;84(6):1594-1601. doi: 10.1016/j.jaad.2020.09.028. Epub 2020 Sep 12.
9
Prevalence of Alopecia Areata in Saudi Arabia: Cross-Sectional Descriptive Study.沙特阿拉伯斑秃的患病率:横断面描述性研究。
Cureus. 2020 Sep 10;12(9):e10347. doi: 10.7759/cureus.10347.
10
Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata.斑秃患者眉毛、睫毛和指甲评估的临床医生报告结局(ClinRO)和患者报告结局(PRO)指标的制定。
Am J Clin Dermatol. 2020 Oct;21(5):725-732. doi: 10.1007/s40257-020-00545-9.